口服药物的体外吸收模型.ppt
- 文档编号:2640551
- 上传时间:2022-11-04
- 格式:PPT
- 页数:43
- 大小:2.23MB
口服药物的体外吸收模型.ppt
《口服药物的体外吸收模型.ppt》由会员分享,可在线阅读,更多相关《口服药物的体外吸收模型.ppt(43页珍藏版)》请在冰豆网上搜索。
InVitroModelsforOralDrugAbsorptionOutlinenPhysicalandBiochemicalBarrierforOralDrugAbsorptionandInVitromodelsfordrugabsorptionnEvaluationoftheMethodCaco-2CellSuitabilitynUseofCaco2andFactorAffectingPermeationofNCEnContinuousDissolution/Caco-2SystemforFormulationScreeningofNCEBLightmicrographofmonkeysmallintestinalmucosaillustratingthethreelayersofthemucosa:
theepithelium(E),thelaminapropria(L),andthemuscularismucosa(M).(takenfromJ.L.MaderaandJ.S.TrierinPhysiologyoftheGastrointestinalTract(L.R.Johnson,Ed.),2ndEdition,RavenPress,NewYork,1987,p.1210)LEMIntestinalMucosa:
APhysicalandBiochemicalBarrierforOralDrugAbsorptionViewofIntestinalMucosa,Pre-1990ACurrentViewofIntestinalMucosa?
BasolateralApicalParacellularDiffusionTranscellularDiffusionMetabolismABEffluxTransportACDMultidrugResistanceTransportersandCYP3AsFormaConcertedBarriertoDrugAbsorptionMultidrugResistanceTransporters(MDR1,MRP2,BCRP)CYP3AsApicalsideBasolateralsideMetabolizedSubstratedrugDrugmetaboliteMDR1(P-glycoprotein,P-gp)Inhibitorse.g.GF120918ABSubstratese.g.DigoxinExamplesofDrugsThatareSubstratesforMDR1CancerdrugsVinblastineVincristineTaxolDaunorubicinEtoposideImmunosuppressiveDrugsCyclosporinAFK506SteroidsDexamethasoneProgesteroneCortisolHIVproteaseinhibitorsAmprenavirIndinavirCardiacdrugsDigoxinQuinidineAnti-goutagentColchicineAntibioticErythromycinAnti-tuberculousagentRifampinSchematicIllustrationofMDR1,MRP1,MRP2,MRP3,MRP5andBCRPinTransfectedPolarizedEpithelialCellsReference:
P.Borstetal.,BBA1461,347-357(1999)J.Jonkeretal.,JNCI92(20),1651-1656(2000)MDR1MRP1MRP2MRP3MRP5ApicalsideBasolateralsideTightjunctionBCRPModelsUsedtoDeterminetheIntestinalMucosalPermeationCharacteristicsofaDrugCandidateOraldosingofanimalsorhumansIntestinalperfusionstudiesinhumansDosingofanimalsthroughachroniccannulaintheintestinallumenInSituintestinalperfusionstudiesinanimalsEffluxtransporter-geneknockoutmiceInVitropermeationstudiesusingexcisedhumanoranimalintestinalmucosaltissuesInVitropermeationstudiesusingcellculturemodelsPAMPA,IAMGastroPlusIntestinalPerfusionStudiesinHumansCorrelationbetweenFractionAbsorbedofd-GlucoseandPhenazoneinHumanRegionalPerfusionStudyDrugAbsorptionStudyinsituandinConsciousRatExtractionforLC/MS/MSAnalysisHPLCAnalysis0.2ml/minCentrifugationBloodFiltrationPerfusateInSituRatIntestinalPerfusionMesentericveinIleumAnimals:
MaleSprague-Dawleyratsweighing350-400gwereused.Perfusionsolution:
NaH2PO4(57.9mM),Na2SO4(79.6mM),pH7.5.PumpDonorBloodJugularveinPapp=DQDtAC0Basolateral(B)Apical(A)CellMonolayerBi-directionalTransportExperimentUsingCaco-2CellMonolayersandCalculationSubstratedrug(e.g.Digoxin)Apicallylocalizedeffluxtransporter(e.g.MDR1)Q/t:
Thelinearappearancerateofmassinthereceiversolution.A:
Cellmonolayersurfacearea.C0:
Theinitialconcentrationinthedonorsolution.PBtoAPAtoBRatioofPBtoA/PAtoB:
AnindicatorofeffluxactivityoftransporterincellmonolayerCorrelationbetweenOralAbsorptioninHumansandMembranePermeability(Papp)inCaco-2CellsP.Arturssonetal.,Adv.DrugDel.Rev.46:
27-43(2001)HistoryofCellCultureModelsUsedtoPredictDrugPermeationacrosstheIntestinalMucosaLate1980s-Mid1990s:
Caco-2cellsMid1990s:
Caco-2cellsvs.MDCKcellsLate1990s:
Caco-2cellsvs.MDCKcellsvs.MDCK-MDR1vs.MDCK-MRP2Caco-2CellMonolayerSystemAdvantagesCellspermitestimationof:
bothcellularuptakeanddrugtransepithelialtransportdrugtransportinthepresenceofmetabolicreactionspolarizedeffluxCellsare:
ofhumanorigin(colonadenocarcinama)viableforlongperiodsDisadvantagesRelativelong-periodoftimeforculture(3weeks)Underexpressionofkeydrug-metabolizingenzymes(e.g.,CYP3A4)Variableexpressionlevelsofeffluxtransporters(e.g.,MDR1,MRP2)PappvaluesinMDCKcellscorrelatedwellwiththoseinCaco-2cellsThecorrelationbetweenMDCKPappvaluesandhumanintestinalabsorptionissimilartotheresultsobservedwithCaco-2MDCKgrowfasterthanCaco-2(1weekvs3weeks)J.D.Irvineetal.,JPS88,28(1999)MDCKCellMonolayerSystemQuestionsConcerningMDCK-MDR1/MDCK-MRP2CellsastheModeloftheIntestinalMucosaMDR1/MRP2cDNAMDCKcellsWhencomparedwithCaco-2cells,dothesecelllines:
expressthesameprotein?
exhibitpolarizedefflux?
exhibitthesamekineticsandaffinityforsubstrates?
MDCK-MDR1/MRP2cellsExpressionofMDR1inCaco-2,MDCK-WT,andMDCK-MDR1CellsM1A1B2A2B3A3B4A4BKD250148M:
marker,A:
5gproteinB:
10gprotein.1:
Caco-2,2:
MDCK-WT,3:
MDCK-MDR1(lowpassage),4:
MDCK-MDR1(highpassage).Ref.:
Tang,F.,Horie,K,andBorchardt,R.T.(2002)AreMDCKcellstransfectedwithhumanMDR1geneagoodmodelofthehumanintestinalmucosa?
Pharm.Res.19765-772Tang,F.,Horie,K,andBorchardt,R.T.(2002)AreMDCKcellstransfectedwithhumanMRP2geneagoodmodelof
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 口服 药物 体外 吸收 模型